TSH levels in patients with TSHoma can be suppressed by short-acting octreotide and do not respond to T3 inhibition tests or TRH stimulation tests, but it should be noted that T3 inhibition tests are contraindicated in the elderly and in patients at high cardiovascular risk. Here, TRH is linked to TSH-secreting pituitary adenoma.